🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial identifies the best dose and side effects of selinexo...
Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Start Date
2021-05-06
Trial ID
NCT04764942
Multiple myeloma (MM) is an incurable plasma cell cancer that almost all pa...
Status
Unknown
Location
Shanghai Changzheng Hospital
Start Date
2022-01-27
Trial ID
NCT04941937
Treatments Being Tested
1\. This is a multi-center clinical study to evaluate dual mTORC1/2 inhibit...
Status
Unknown
Location
Chongqing Cancer Hospital
Start Date
2021-08-03
Trial ID
NCT04998760
This phase I/II trial tests the safety, side effects, and best dose of seli...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2022-05-31
Trial ID
NCT05099003
Treatments Being Tested
This phase I/II trial tests the safety, side effects and best dose of selin...
Status
Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2023-03-20
Trial ID
NCT05432804
Treatments Being Tested
This phase Ib/II trial finds the best dose of selinexor and its effect with...
Status
Terminated
Location
University of California Davis Comprehensive Cancer Center
Start Date
2021-04-08
Trial ID
NCT04856189
Treatments Being Tested
This is an open-label, single arm, and registered study of ATG-010 in Patie...
Status
Completed
Location
Anhui Province Cancer Hospital
Start Date
2020-04-09
Trial ID
NCT03992339
Treatments Being Tested
This is an Open label, Phase Ⅰb Study of ATG-010 in Combination With ATG-00...
Status
Terminated
Location
Chongqing Cancer Hospital
Start Date
2022-03-02
Trial ID
NCT05354362
Treatments Being Tested
This is a Phase III Randomized, Controlled, Multicenter, Open-label Study o...
Status
Completed
Location
The First Affiliated Hospital of Anhui Medical University
Start Date
2021-07-12
Trial ID
NCT04939142
Treatments Being Tested
This is a single-arm and open-label study to explore XVRd (ATG-010, Bortezo...
Status
Unknown
Location
Guangdong Provincial Peoples Hospital
Start Date
2022-07-25
Trial ID
NCT05422027
Treatments Being Tested